DK169818B1 - Ergolinderivater, fremgangsmåde til fremstilling deraf, samt farmaceutisk præparat indeholdende disse - Google Patents

Ergolinderivater, fremgangsmåde til fremstilling deraf, samt farmaceutisk præparat indeholdende disse Download PDF

Info

Publication number
DK169818B1
DK169818B1 DK254687A DK254687A DK169818B1 DK 169818 B1 DK169818 B1 DK 169818B1 DK 254687 A DK254687 A DK 254687A DK 254687 A DK254687 A DK 254687A DK 169818 B1 DK169818 B1 DK 169818B1
Authority
DK
Denmark
Prior art keywords
methyl
pharmaceutically acceptable
ergoline
reduction
represents hydrogen
Prior art date
Application number
DK254687A
Other languages
Danish (da)
English (en)
Other versions
DK254687D0 (da
DK254687A (da
Inventor
Aldemio Temperilli
Roberto Maj
Sergoi Mantegani
Enzo Brambilla
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of DK254687D0 publication Critical patent/DK254687D0/da
Publication of DK254687A publication Critical patent/DK254687A/da
Application granted granted Critical
Publication of DK169818B1 publication Critical patent/DK169818B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DK254687A 1986-05-21 1987-05-19 Ergolinderivater, fremgangsmåde til fremstilling deraf, samt farmaceutisk præparat indeholdende disse DK169818B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8612366 1986-05-21
GB868612366A GB8612366D0 (en) 1986-05-21 1986-05-21 Ergoline esters

Publications (3)

Publication Number Publication Date
DK254687D0 DK254687D0 (da) 1987-05-19
DK254687A DK254687A (da) 1987-11-22
DK169818B1 true DK169818B1 (da) 1995-03-06

Family

ID=10598207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254687A DK169818B1 (da) 1986-05-21 1987-05-19 Ergolinderivater, fremgangsmåde til fremstilling deraf, samt farmaceutisk præparat indeholdende disse

Country Status (20)

Country Link
US (1) US4785001A (ko)
EP (1) EP0249761B1 (ko)
JP (1) JPH0723375B2 (ko)
KR (1) KR950006866B1 (ko)
AT (1) ATE82287T1 (ko)
AU (1) AU588109B2 (ko)
CA (1) CA1292224C (ko)
DE (1) DE3782548T2 (ko)
DK (1) DK169818B1 (ko)
ES (1) ES2052512T3 (ko)
FI (1) FI85142C (ko)
GB (1) GB8612366D0 (ko)
GR (1) GR3006298T3 (ko)
HU (1) HU196069B (ko)
IE (1) IE60655B1 (ko)
IL (1) IL82556A (ko)
NZ (1) NZ220341A (ko)
PT (1) PT84897B (ko)
SU (1) SU1549482A3 (ko)
ZA (1) ZA873592B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
GB8615471D0 (en) * 1986-06-25 1986-07-30 Erba Farmitalia T-butyl ergoline derivatives
ATE204278T1 (de) * 1992-12-24 2001-09-15 Pharmacia & Upjohn Spa Serotoninergische ergolin derivate
GB9407637D0 (en) 1994-04-18 1994-06-08 Erba Carlo Spa Serotoninergic abeo-ergoline derivatives
GB9603226D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Heterocyclyl-ergoline derivatives
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
DE10018834A1 (de) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879554A (en) * 1970-03-20 1975-04-22 Farmaceutici Italia Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders
FR2189046B1 (ko) * 1972-06-22 1978-07-28 Farmaceutici Italia
US4057635A (en) * 1973-05-23 1977-11-08 Simes Societa Italiana Medicinali E Sintetici S.P.A. Carbamates of ergolines and therapeutic compositions therewith
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
YU39278B (en) * 1976-12-22 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing 5-bromo nicotinic acid esters

Also Published As

Publication number Publication date
GR3006298T3 (ko) 1993-06-21
JPS62294682A (ja) 1987-12-22
IL82556A (en) 1991-06-10
IL82556A0 (en) 1987-11-30
HUT44542A (en) 1988-03-28
FI872174A (fi) 1987-11-22
ES2052512T3 (es) 1994-07-16
KR950006866B1 (ko) 1995-06-23
NZ220341A (en) 1989-06-28
PT84897A (en) 1987-06-01
AU7316887A (en) 1987-11-26
FI85142B (fi) 1991-11-29
AU588109B2 (en) 1989-09-07
EP0249761B1 (en) 1992-11-11
EP0249761A2 (en) 1987-12-23
DE3782548T2 (de) 1993-04-22
CA1292224C (en) 1991-11-19
IE871291L (en) 1987-11-21
IE60655B1 (en) 1994-08-10
HU196069B (en) 1988-09-28
DK254687D0 (da) 1987-05-19
FI872174A0 (fi) 1987-05-18
ATE82287T1 (de) 1992-11-15
FI85142C (fi) 1992-03-10
ZA873592B (en) 1987-11-12
DE3782548D1 (de) 1992-12-17
EP0249761A3 (en) 1989-05-10
SU1549482A3 (ru) 1990-03-07
JPH0723375B2 (ja) 1995-03-15
PT84897B (pt) 1990-02-08
DK254687A (da) 1987-11-22
KR870011134A (ko) 1987-12-21
GB8612366D0 (en) 1986-06-25
US4785001A (en) 1988-11-15

Similar Documents

Publication Publication Date Title
DE69824632T2 (de) Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
EP0063381A1 (de) Neue Pyrazolo(3,4-d)pyrimidine, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
JPS6072891A (ja) ピリミド〔4,5−g〕キノリンおよびその製造中間体
JPH0457675B2 (ko)
JPS60136592A (ja) N↑6‐(1‐および2‐ベンゾシクロアルキル)アデノシンおよびその製法
JPS5869812A (ja) 血糖降下剤
JPH0428269B2 (ko)
DK169818B1 (da) Ergolinderivater, fremgangsmåde til fremstilling deraf, samt farmaceutisk præparat indeholdende disse
DE68911776T2 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
CA1299574C (en) (1)-1.beta.-ETHYL-1.alpha.-HYDROXYMETHYL-1,2,3,4,6,7,12,12-.beta. .alpha.-OCTAHYDROINDOLO ¬2,3-A| QUINOLIZINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
DE3785076T2 (de) Pyrido(4,3-d)pyrimidin-derivate.
US4512994A (en) Long-acting theophylline in medicinal form
JPH0339513B2 (ko)
EP0665014B1 (de) 3-Benzoyl-3,7-diazabicyclo(3,3,1)nonan-Verbindungen mit anti-arrhythmischer Wirkung
JPS6078982A (ja) ナフタレニルイミダゾピリジンおよびその誘導体ならびにその製造法
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
JP4223237B2 (ja) 3−フェニル−3,7−ジアザビシクロ[3,3,1]ノナン−化合物、これを含有する医薬品、その使用及びその製法
GB2171995A (en) Pharmaceutically active 8-heteroarylthio-5, 6, 7, 8-tetrahydroquinolines
US4732906A (en) Dioxolobenzizoxazole derivatives
US4419367A (en) Stimulant
JPS62158274A (ja) 置換−1,3−ジチエタン誘導体
LU85193A1 (fr) Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation
JPH03128385A (ja) 3―エキソメチレンピロロ[2,1―b]チアゾール誘導体
JPS6038397B2 (ja) チアジノイミダゾ−ル誘導体及びその製造法
JPH0256424A (ja) 肝疾患治療剤

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed